(PATH) Uipath - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90364P1057

PATH: Robotic Process Automation, AI, Cloud, Low-Code, Process Mining

UiPath Inc. is a leading provider of an end-to-end automation platform that enables organizations to streamline operations through advanced robotic process automation (RPA) solutions. With a strong presence in the United States, Romania, the United Kingdom, the Netherlands, and other international markets, the company delivers software robots capable of mimicking human actions with high precision and speed. Its platform integrates AI, ML, and NLP capabilities to enhance decision-making and information processing, allowing users to combine UI automations, API integrations, and AI-based document understanding into a single workflow. The platform also offers multi-tenant enterprise deployment with robust security and governance features, as well as Automation Cloud for rapid deployment without infrastructure overhead. Its intuitive, low-code interface with drag-and-drop functionality empowers users to design and execute automations efficiently. Additionally, UiPath provides process mining capabilities to analyze digital footprints, track automation performance, and generate actionable insights for continuous process optimization. The company serves a diverse range of industries, including financial services, healthcare, manufacturing, retail, and the public sector. Founded in 2005 and headquartered in New York, UiPath has established itself as a pioneer in the RPA space, driving digital transformation for enterprises globally.

3-Month Forecast: Based on the provided and , UiPath Inc. (NYSE:PATH) is expected to experience sideways price action with potential upside in the near term. The stock is currently trading above its SMA20 but below its SMA50 and SMA200, indicating a potential recovery phase. The ATR of 0.54 suggests moderate volatility, while the forward P/E of 19.01 reflects investor confidence in future growth. With a market cap of $5.763B and a P/S ratio of 4.03, UiPath is well-positioned for expansion, though the negative RoE of -3.99 highlights the need for improved profitability. Overall, the stock is likely to remain range-bound with a slight bullish bias if the company meets earnings expectations.

Additional Sources for PATH Stock

PATH Stock Overview

Market Cap in USD 5,763m
Sector Technology
Industry Software - Infrastructure
GiC Sub-Industry Systems Software
IPO / Inception 2021-04-21

PATH Stock Ratings

Growth Rating -64.4
Fundamental 25.6
Dividend Rating 0.0
Rel. Strength -44.1
Analysts 3.13/5
Fair Price Momentum 8.17 USD
Fair Price DCF 4.94 USD

PATH Dividends

No Dividends Paid

PATH Growth Ratios

Growth Correlation 3m -74.4%
Growth Correlation 12m -21.3%
Growth Correlation 5y -71.1%
CAGR 5y -35.33%
CAGR/Max DD 5y -0.40
Sharpe Ratio 12m -0.07
Alpha -54.92
Beta 1.411
Volatility 62.01%
Current Volume 11389.3k
Average Volume 20d 16219.2k
What is the price of PATH stocks?
As of May 02, 2025, the stock is trading at USD 11.88 with a total of 11,389,257 shares traded.
Over the past week, the price has changed by +4.95%, over one month by +13.14%, over three months by -16.40% and over the past year by -38.25%.
Is Uipath a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Uipath is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 25.60 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PATH as of May 2025 is 8.17. This means that PATH is currently overvalued and has a potential downside of -31.23%.
Is PATH a buy, sell or hold?
Uipath has received a consensus analysts rating of 3.13. Therefor, it is recommend to hold PATH.
  • Strong Buy: 2
  • Buy: 1
  • Hold: 20
  • Sell: 0
  • Strong Sell: 1
What are the forecast for PATH stock price target?
According to ValueRays Forecast Model, PATH Uipath will be worth about 9.8 in May 2026. The stock is currently trading at 11.88. This means that the stock has a potential downside of -17.76%.
Issuer Forecast Upside
Wallstreet Target Price 12.3 3.6%
Analysts Target Price 15.7 31.9%
ValueRay Target Price 9.8 -17.8%